Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 23032990)

1.

A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease.

Hill-Burns EM, Singh N, Ganguly P, Hamza TH, Montimurro J, Kay DM, Yearout D, Sheehan P, Frodey K, McLear JA, Feany MB, Hanes SD, Wolfgang WJ, Zabetian CP, Factor SA, Payami H.

Pharmacogenomics J. 2013 Dec;13(6):530-7. doi: 10.1038/tpj.2012.38. Epub 2012 Oct 2.

2.

Gut feelings about smoking and coffee in Parkinson's disease.

Derkinderen P, Shannon KM, Brundin P.

Mov Disord. 2014 Jul;29(8):976-9. doi: 10.1002/mds.25882. Epub 2014 Apr 21.

3.

CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking.

Bar-Shira A, Gana-Weisz M, Gan-Or Z, Giladi E, Giladi N, Orr-Urtreger A.

Neurobiol Aging. 2014 Sep;35(9):2179.e1-6. doi: 10.1016/j.neurobiolaging.2014.03.014. Epub 2014 Mar 20.

PMID:
24731518
4.

Nicotine increases lifespan and rescues olfactory and motor deficits in a Drosophila model of Parkinson's disease.

Chambers RP, Call GB, Meyer D, Smith J, Techau JA, Pearman K, Buhlman LM.

Behav Brain Res. 2013 Sep 15;253:95-102. doi: 10.1016/j.bbr.2013.07.020. Epub 2013 Jul 16.

5.

Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.

Chung SJ, Jung Y, Hong M, Kim MJ, You S, Kim YJ, Kim J, Song K.

Neurobiol Aging. 2013 Nov;34(11):2695.e1-7. doi: 10.1016/j.neurobiolaging.2013.05.022. Epub 2013 Jun 29.

PMID:
23820587
6.

Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

Chung SJ, Armasu SM, Anderson KJ, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Ahlskog JE, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2013 Jun;19(6):595-9. doi: 10.1016/j.parkreldis.2013.02.008. Epub 2013 Mar 16.

PMID:
23507417
7.

RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.

MacLeod DA, Rhinn H, Kuwahara T, Zolin A, Di Paolo G, McCabe BD, Marder KS, Honig LS, Clark LN, Small SA, Abeliovich A.

Neuron. 2013 Feb 6;77(3):425-39. doi: 10.1016/j.neuron.2012.11.033. Erratum in: Neuron. 2013 Mar 6;77(5):994. MacCabe, Brian D [corrected to McCabe, Brian D].

8.

The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.

Dardiotis E, Xiromerisiou G, Hadjichristodoulou C, Tsatsakis AM, Wilks MF, Hadjigeorgiou GM.

Toxicology. 2013 May 10;307:17-23. doi: 10.1016/j.tox.2012.12.016. Epub 2013 Jan 4. Review.

PMID:
23295711
9.

Pathway analysis of genome-wide association studies for Parkinson's disease.

Song GG, Lee YH.

Mol Biol Rep. 2013 Mar;40(3):2599-607. doi: 10.1007/s11033-012-2346-9. Epub 2012 Dec 13.

PMID:
23238920
10.

Is nicotine protective against Parkinson's disease? An experimental analysis.

García-Montes JR, Boronat-García A, López-Colomé AM, Bargas J, Guerra-Crespo M, Drucker-Colín R.

CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):897-906.

PMID:
23131151
11.

Lack of association between BST1 polymorphisms and sporadic Parkinson's disease in a Japanese population.

Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

J Neurol Sci. 2012 Dec 15;323(1-2):162-6. doi: 10.1016/j.jns.2012.09.008. Epub 2012 Sep 29.

PMID:
23026536
12.

Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interaction.

Greenbaum L, Rigbi A, Lipshtat N, Cilia R, Tesei S, Asselta R, Djaldetti R, Goldwurm S, Lerer B.

Parkinsonism Relat Disord. 2013 Jan;19(1):72-6. doi: 10.1016/j.parkreldis.2012.07.007. Epub 2012 Aug 9.

PMID:
22884254
13.

Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Cannon JR, Greenamyre JT.

Neurobiol Dis. 2013 Sep;57:38-46. doi: 10.1016/j.nbd.2012.06.025. Epub 2012 Jul 7. Review.

14.

[Genetic aspects in nicotine dependence].

Korhonen T, Kaprio J.

Duodecim. 2012;128(10):1065-71. Review. Finnish.

PMID:
22724321
15.

Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease.

Ling H, Petrovic I, Day BL, Lees AJ.

J Neurol. 2012 Nov;259(11):2419-23. doi: 10.1007/s00415-012-6515-5. Epub 2012 May 10.

PMID:
22573395
16.

SNCA polymorphisms, smoking, and sporadic Parkinson's disease in Japanese.

Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

Parkinsonism Relat Disord. 2012 Jun;18(5):557-61. doi: 10.1016/j.parkreldis.2012.02.016. Epub 2012 Mar 17.

PMID:
22425546
17.

Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunction.

Ali SF, Binienda ZK, Imam SZ.

Int J Environ Res Public Health. 2011 Dec;8(12):4702-13. doi: 10.3390/ijerph8124702. Epub 2011 Dec 16. Review.

18.

Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.

Soreq L, Ben-Shaul Y, Israel Z, Bergman H, Soreq H.

Neurobiol Dis. 2012 Mar;45(3):1018-30. doi: 10.1016/j.nbd.2011.12.021. Epub 2011 Dec 16.

PMID:
22198569
19.

Can nicotine be used medicinally in Parkinson's disease?

Thiriez C, Villafane G, Grapin F, Fenelon G, Remy P, Cesaro P.

Expert Rev Clin Pharmacol. 2011 Jul;4(4):429-36. doi: 10.1586/ecp.11.27. Review.

PMID:
22114853
20.

Early exposure to paraquat sensitizes dopaminergic neurons to subsequent silencing of PINK1 gene expression in mice.

Zhou H, Huang C, Tong J, Xia XG.

Int J Biol Sci. 2011;7(8):1180-7. Epub 2011 Oct 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk